ada standards of care 2025 obesity pharmacotherapy glp-1 recommendations Updates in Medicine | Choosing the Right Diabetic Medication 🩸💊 (Related to last post) • Tables above highlight key properties diabetic medications. • Use 2025 ADA Diabetes Care Updates

Although the subjects were non-diabetic, one meaningful study observed acute changes of cardiovascular risk markers such as HR and BP upon intravenous administration of GLP-1 RA [38]

Prescription rate of GLP-1s based on diagnosis Source: Piaopiao, L et al JAMA Network Open October 31, 2025 Research published in JAMA Network Open evaluated trends in prescribing of GLP-1 agents from 2010 through the end of 2024 using the Cosmos data warehouse, which has at least some medical records for 300 million Americans

Novos Wegovy was approved in the country in June, followed closely by Lillys Zepbound

And it runs deeper than aspiration